Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families
Authors:
- Tadeusz DębniakTDTadeusz Dębniak
- Tomasz GromowskiTGTomasz Gromowski
- Rodney J ScottRodney J Scott
- Jacek GronwaldJGJacek Gronwald
- Tomasz HuzarskiTHTomasz Huzarski
- Tomasz ByrskiTBTomasz Byrski
- Grzegorz KurzawskiGKGrzegorz Kurzawski
- Dagmara DymerskaDDDagmara Dymerska
- Bohdan GórskiBGBohdan Górski
- Katarzyna Paszkowska-SzczurKPKatarzyna Paszkowska-Szczur
- Cezary CybulskiCCCezary Cybulski
- Pablo Serrano-FernandezPSPablo Serrano-Fernandez
Open Access
- 16 January 2015
- journal article
- review article
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 13 (1) , 3
Abstract
Over half the cancer deaths in HNPCC families are due to extra-colonic malignancies that include endometrial and ovarian cancers. The benefits of surveillance for gynecological cancers are not yet proven and there is no consensus on the optimal surveillance recommendations for women with MMR mutations. We performed a systematic review of the literature and evaluated gynecological cancer risk in a series of 631 Polish HNPCC families classified into either Lynch Syndrome (LS, MMR mutations detected) or HNPCC (fulfillment of the Amsterdam or modified Amsterdam criteria). Published data clearly indicates no benefit for ovarian cancer screening in contrast to risk reducing surgery. We confirmed a significantly increased risk of OC in Polish LS families (OR = 4,6, p < 0.001) and an especially high risk of OC was found for women under 50 years of age: OR = 32,6, p < 0.0001 (95% CI 12,96-81,87). The cumulative OC risk to 50 year of life was calculated to be 10%. Six out of 19 (32%) early-onset patients from LS families died from OC within 2 years of diagnosis. We confirmed a significantly increased risk of EC (OR = 26, 95% CI 11,36-58,8; p < 0,001). The cumulative risk for EC in Polish LS families was calculated to be 67%. Due to the increased risk of OC and absence of any benefit from gynecological screening reported in the literature it is recommended that prophylactic oophorectomy for female carriers of MMR mutations after 35 year of age should be considered as a risk reducing option. Annual transvaginal ultrasound supported by CA125 or HE4 marker testing should be performed after prophylactic surgery in these women. Due to the high risk of EC it is reasonable to offer, after the age of 35 years, annual clinical gynecologic examinations with transvaginal ultrasound supported by routine aspiration sampling of the endometrium for women from either LS or HNPCC families. An alternative option, which could be taken into consideration for women preferring surgical prevention, is risk reducing total hysterectomy (with bilateral salpingo-oophorectomy) for carriers after childbearing is complete.Keywords
This publication has 60 references indexed in Scilit:
- Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature reviewHereditary Cancer in Clinical Practice, 2013
- Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsGut, 2013
- Risks of Less Common Cancers in Proven Mutation Carriers With Lynch SyndromeJournal of Clinical Oncology, 2012
- Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registryFamilial Cancer, 2012
- Clinicopathological Features and Management of Cancers in Lynch SyndromePathology Research International, 2012
- Prospective Study of Combined Colon and Endometrial Cancer Screening in Women With Lynch Syndrome: A Patient-Centered ApproachJournal of Oncology Practice, 2011
- Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindredsJournal of Medical Genetics, 2009
- Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndromeFamilial Cancer, 2009
- The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndromeInternational Journal of Cancer, 2008
- Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndromeInternational Journal of Cancer, 1995